Zdrowie i gospodarka · 09/04/1997

FDA Announces Opportunity for Hearing on Proposal to Revoke SEF, P.A.'s License for Whole Blood and Red Blood Cells Manufacturing

The FDA is seeking public input on a proposal to revoke the licenses of SEF, P.A., doing business as National Health Guard, Inc., for manufacturing whole blood and red blood cells, citing the establishment's inability to conduct meaningful inspections due to its discontinuation of product manufacturing.